“Nutraceutical contractor trims fat, but skips shareholder payouts.”
No clear market view today
The signals we track (volume, delivery, price trend, deals, breadth and flows) aren't aligned for WALPAR today. That isn't bearish, just inconclusive.
RSI indicates oversold conditions
India-specific risk checks.
Four fundamentals lenses on the company itself: valuation, growth, returns & margins, and financial health, judged against the stock's sector. A separate read from the Market Setup above.
Trading at attractive valuations
₹1,000 invested here buys about ₹227 of annual profit. A cheaper stock would buy more.
Steady growth
Moderate returns
Strong balance sheet
Data as of 11 Sept 2026, 9:48 pm